A new study suggests that states that backed President Donald Trump in the 2024 presidential election are seeing overall increases in young children and young families, while states that voted for ...
state government is considering a birth incentive for couples from their second child onwards to boost the falling birth rate ...
What drove the state to No. 6? Subscribers are citing ethical reasons for paying creators directly rather than supporting ...
PRAME Cell Therapy: Global, randomized, controlled Phase 3 trial, SUPRAME, in previously treated advanced melanoma ongoing; anzu-cel received Orphan Drug Designation from the FDA for the treatment of ...
Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarter2025 year-end cash and cash equivalents of $226.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results